Evidence map›Paper›PMID 8636005›Full record

ArticleJapanese journal of cancer research : Gann1995

Expression of CD44 variant exons 8-10 in gastric cancer.

A Yamaguchi, M Saito, T Gio, A Iida, K Takeuchi, K Hirose, G Nakagawara, T Urano, K Furukawa, H Shiku

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Japanese journal of cancer research : Gann, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. CD44 family proteins in gastric cancer: a meta-analysis and narrative review.International journal of clinical and experimental medicine · 2015
    Article
  9. Review
  10. CD44 and the adhesion of neoplastic cells.Molecular pathology : MP · 1997
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

A YamaguchiFirst Department of Surgery, Fukui Medical School.
M Saito
T Gio
A Iida
K Takeuchi
K Hirose
G Nakagawara
T Urano
K Furukawa
H Shiku
University of Fukui · JPNagasaki University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The expression of CD44 variant containing variant exons 8-10 product (CD44v8-10) was studied by western blot analysis and immunohistochemistry in gastric cancers using a monoclonal antibody, 44-1V. On western blots, a single band of 130 kD was recognized in stomach cancer cell lines. CD44v8-10 expression, with reactivity localized in the cell membrane, was found in 65 (33.5%) of the 194 advanced gastric cancers. There was no correlation between CD44v8-10 immunoreactivity and serosal, lymphatic, or lymph node invasion. However, there was significant correlation with CD44v8-10 immunoreactivity and venous invasion. CD44v8-10-positive cancers were more frequently associated with hematogenous metastasis than those which were immunonegative. There was an inverse association between CD44v8-10 immunoreactivity and peritoneal dissemination, especially in diffuse type adenocarcinomas. These observations indicate that CD44v8-10 may play a role in the metastasis of gastric cancer.

Indexed as

Gene Expression Regulation, NeoplasticNeoplasm MetastasisAdenocarcinomaAntibodies, MonoclonalAntigens, NeoplasmBlotting, WesternCarcinomaExonsHumansHyaluronan ReceptorsLymphatic MetastasisNeoplastic Cells, CirculatingRecombinant Fusion ProteinsStomach NeoplasmsAntibodies, MonoclonalAntigens, NeoplasmHyaluronan ReceptorsRecombinant Fusion Proteins

Identifiers

PMID8636005
PMCPMC5920665
OpenAlexW1979061512

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.